Evidence map›Paper›PMID 36235179›Full record

ArticleMolecules (Basel, Switzerland)2022

Absolute Configuration and Biological Evaluation of Novel Triterpenes as Possible Anti-Inflammatory or Anti-Tumor Agents.

Zhenzhen Wei, Tiqiang Zhou, Ziming Xia, Sifan Liu, Min Li, Guangjie Zhang, Ying Tian, Bin Li, Lin Wang, Shuchen Liu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. LC-HR/MS Analysis of Lipophilic Extracts fromMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhenzhen WeiFaculty of Environment and Life, Beijing University of Technology, Beijing 100022, China.
Tiqiang ZhouFaculty of Environment and Life, Beijing University of Technology, Beijing 100022, China.
Ziming XiaDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Sifan LiuDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Min LiDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Guangjie ZhangDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Ying TianDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Bin LiDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Lin WangDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.
Shuchen LiuDepartment of Pharmaceutical Science, Beijing Institute of Radiation Medicine, Beijing 100850, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two new compounds, ardisiapunine B (

Indexed as

Antineoplastic AgentsOleanolic AcidTriterpenesAcetalsAldehydesAnti-Inflammatory AgentsLipopolysaccharidesMolecular StructureAcetalsAldehydesAnti-Inflammatory AgentsAntineoplastic AgentsLipopolysaccharidesOleanolic AcidTriterpenesabsolute configurationsArdisia lindleyana D. Dietrardisiapunine Bardisiapunine Cbiological activitysingle–crystal X–ray diffractiontriterpene

Identifiers

PMID36235179
PMCPMC9572544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.